首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   103343篇
  免费   9201篇
  国内免费   4417篇
耳鼻咽喉   1316篇
儿科学   1687篇
妇产科学   1147篇
基础医学   12226篇
口腔科学   2329篇
临床医学   12255篇
内科学   15712篇
皮肤病学   2686篇
神经病学   5156篇
特种医学   4834篇
外国民族医学   22篇
外科学   10296篇
综合类   13797篇
现状与发展   19篇
一般理论   13篇
预防医学   7680篇
眼科学   2143篇
药学   11253篇
  80篇
中国医学   5257篇
肿瘤学   7053篇
  2024年   219篇
  2023年   1068篇
  2022年   2811篇
  2021年   4569篇
  2020年   3249篇
  2019年   2942篇
  2018年   3159篇
  2017年   3109篇
  2016年   3316篇
  2015年   5029篇
  2014年   6167篇
  2013年   6702篇
  2012年   9741篇
  2011年   9714篇
  2010年   6795篇
  2009年   5645篇
  2008年   6767篇
  2007年   6188篇
  2006年   5754篇
  2005年   5035篇
  2004年   3661篇
  2003年   3185篇
  2002年   2695篇
  2001年   1761篇
  2000年   1496篇
  1999年   1131篇
  1998年   546篇
  1997年   549篇
  1996年   386篇
  1995年   335篇
  1994年   324篇
  1993年   210篇
  1992年   300篇
  1991年   310篇
  1990年   247篇
  1989年   211篇
  1988年   170篇
  1987年   148篇
  1986年   133篇
  1985年   105篇
  1984年   74篇
  1983年   55篇
  1981年   43篇
  1980年   45篇
  1979年   78篇
  1978年   49篇
  1975年   57篇
  1972年   47篇
  1971年   55篇
  1970年   39篇
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
91.
【目的】了解手术创伤对术后全身炎症反应综合征 (SIRS)的影响。【方法】搜集外科重症监护室 (SICU) 335例患者的术后资料 ,分析不同手术组SIRS发病率 ;手术时间、失血量与SIRS持续时间的关系 ;SIRS持续时间与术后并发症的关系。【结果】术后SIRS发病率为 75 8% ,大手术高达 92 4 % ;无并发症患者失血量与SIRS持续时间呈正相关 (r1=0 783,P<0 0 1) ,手术时间与SIRS持续时间呈正相关 (r2 =0 398,P <0 0 1) ;随着SIRS持续时间延长 ,并发症发病率显著增高 (P<0 0 5 )。【结论】术后SIRS发生、发展与手术创伤密切相关 ;监测SIRS进程有助于及早发现并发症  相似文献   
92.
目的:分析胸腰段脊柱前路手术入路并发症,以提高胸腰段脊柱前路手术的水平,方法:对近4年来我科53例胸腰段脊柱前路手术出现的5例并发症进行回顾性分析,探讨并发症发生的原因。结果;本组病例1例发生腹膜后乳糜液漏,1例切口疝,1例气胸,2例深静脉血栓栓塞,经过积极治疗,全部治愈。结论:胸腰段脊柱前路手术并发症的发生大多数和术者对该段解剖知识,手术操作,认识程度和经验有关,可以避免或及早发现。  相似文献   
93.
This study was conducted to investigate the hypocholesterolemic effect of simvastatin (30 mg/kg BW) and antioxidant effect of coenzyme Q10 (CoQ10, 15 mg/kg BW) or green tea (5%) on erythrocyte Na leak, platelet aggregation and TBARS production in hypercholesterolemic rats treated with statin. Food efficiency ratio (FER, ADG/ADFI) was decreased in statin group and increased in green tea group, and the difference between these two groups was significant (p<0.05). Plasma total cholesterol was somewhat increased in all groups with statin compared with control. Plasma triglyceride was decreased in statin group and increased in groups of CoQ10 and green tea, and the difference between groups of statin and green tea was significant (p<0.05). Liver total cholesterol was not different between the control and statin group, but was significantly decreased in the group with green tea compared with other groups (p<0.05). Liver triglyceride was decreased in groups of statin and green tea compared with the control, and the difference between groups of the control and green tea was significant (p<0.05). Platelet aggregation of both the initial slope and the maximum was not significantly different, but the group with green tea tended to be higher in initial slope and lower in the maximum. Intracellular Na of group with green tea was significantly higher than the control or statin group (p<0.05). Na leak in intact cells was significantly decreased in the statin group compared with the control (p<0.05). Na leak in AAPH treated cells was also significantly reduced in the statin group compared with groups of the control and CoQ10 (p<0.05). TBARS production in platelet rich plasma was significantly decreased in the groups with CoQ10 and green tea compared with the control and statin groups (p<0.05). TBARS of liver was significantly decreased in the group with green tea compared with the statin group (p<0.05). In the present study, even a high dose of statin did not show a cholesterol lowering effect, therefore depletion of CoQ10 following statin treatment in rats is not clear. More clinical studies are needed for therapeutic use of CoQ10 as an antioxidant in prevention of degenerative diseases independent of statin therapy.  相似文献   
94.
抗前列腺增生药SL—89.0519—08的合成   总被引:1,自引:1,他引:0       下载免费PDF全文
目的:研究治疗前列腺增生的α1-受体拮抗剂SL-89.0519-08的合成路线。方法:以5-氯-2-甲氧基苯胺为原料,经环合,烃化,脱保护基和亲核取代等步骤,合成了目标化合物,同时对原料合成工艺进行了摸索。结果:合成的目标化合物经IR,^1HMNR,EI-MS和HRMS得以确证。结论:该合成工艺和路线适宜工业化生产。  相似文献   
95.
96.
Critical size defect in the canine mandible.   总被引:3,自引:0,他引:3  
OBJECTIVE: The purpose of this study was to determine the minimum size defect in a canine mandible that would not spontaneously heal during the dog's natural life (the critical size defect). STUDY DESIGN: Sixteen adult female mongrel dogs underwent continuity resection on both sides of the mandible to create bilateral defects. In 8 dogs, mandibular defects ranging from 5 to 20 mm were created with periosteal resection. In the other 8 dogs, mandibular defects ranging from 30 to 60 mm were created preserving the periosteum. The dogs were then killed at 6 months and the defects examined using radiographs and histologic analysis. RESULTS: When the periosteum was removed, mandibular defects greater than 15 mm failed to heal across the entire defect. However, when the periosteum was preserved, mandibular defects needed to be greater than 50 mm in order to fail to heal. CONCLUSION: The critical size defect in a canine mandible model is 15 mm when the periosteum is removed and 50 mm when the periosteum is preserved.  相似文献   
97.
外科护理文书存在的风险及管理对策   总被引:5,自引:4,他引:1  
对外科护理文书的风险细节管理中存在的问题进行阐述,提出强化外科护士的法律意识,树立风险源于细节的管理意识,保证护理文书记录的科学性、及时性、准确性及真实性,注重护患沟通,提高护理质量是降低护理风险,避免医疗纠纷发生的关键。  相似文献   
98.
Objective To test the hypothesis that p53 gene therapy combined with endostatin can enhance tumor response to radiation therapy of RM-1 mouse xenograft prostate cancer and to investigate its mechanism. Methods A mouse prostate cancer model was established. Then mice with xenograft tumor were randomly divided into group A (control), B (radiation), C (radiation and rAdp53), D (radiation and rh-endostatin) and E (radiation and rAdp53 and rh-endostatin). On day 1, rAdp53 was injected intra-tumorously with 1 × 1010 vp per animal to group C and E. From day 1 to 14, rh-endostatin was given 15 mg/kg intraperitoneally daily to group D and E. On day 4 single fraction of 15 Gy was given to tumors in groups B, C, D and E. Normal saline was injected intra-tumorously or intraperitoneaUy accordingly as control. No treatment was done to group A. Tumor volume was measured daily. Samples were collected on Days 5, 10 and 15. Ki67, CD31, p53 and VEGF were detected by means of immunohistochemistry. Results (1) Radiation alone, radiation combined with intra-tumorous injection of Adp53 and/or intraperitoneal injection of rh-endostatin resulted in tumor growth arrest of RM-1 cells in vivo (P = 0.000). Radiation combined with both rAdp53 and rh-endostatin was the most effective treatment (P < 0.05). (2) All the four treatment groups had a decreased expression of mutant type P53 (P = 0.000). The expression of Ki67 in groups B and C were equal (P 0.05) and increasing (P = 0.000), respectively. Group D had a up-down-up curve (P < 0.05), but group E had a up-down one. On day 5 the expresion of VEGF in group E was the lowest (P < 0.05). An increased expression of MVD compared with the control was shown, and MVD in groups C, D and E were always higher than that in the control (P < 0.05). Conclusions The limitation of radiotherapy could be overcome by combination with beth p53 gene therapy and endostatin on the growth of mouse prostate cancer cell. Radiation, rAdp53 and endostatin have their own role but they can be interacted with each other.  相似文献   
99.
100.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号